Delineate vs Palo Alto Networks
Side-by-side comparison of AI visibility scores, market position, and capabilities
US AI clinical trial design and systematic review automation extracting data from papers and figures at 15x industry speed for two top-10 pharma partners; competing with Elsevier Reaxys for biopharma evidence synthesis that reduces study times from months to weeks.
About
Delineate is a United States-based AI clinical trial design and biomedical data extraction company — providing pharmaceutical companies, academic research teams, and contract research organizations (CROs) with AI-powered systematic review automation that accelerates the data extraction and evidence synthesis workflows critical for designing better, faster clinical trials in the $10 billion clinical trial design and data services market. Partnered with two top-10 global pharmaceutical companies, Delineate has performed some of the largest systematic-review studies ever conducted in drug development, delivering 15x more processed studies than industry standard timelines and reducing certain study completion times from months to weeks through AI models that extract and analyze data from biopharma research papers, patents, and regulatory documents at scale.
Santa Clara cybersecurity platform (NASDAQ: PANW) $8.0B FY2024 revenue (+16%); platformization 3,600+ customers, Cortex XSIAM AI SOC, $4.2B NGSSAR +42%, competing with CrowdStrike and Microsoft Defender.
About
Palo Alto Networks, Inc. is a Santa Clara, California-based cybersecurity platform company — publicly traded on the NASDAQ (NASDAQ: PANW) as an S&P 500 Information Technology component — providing network security, cloud security, and AI-driven security operations through three integrated security platforms: Strata (network security — next-generation firewalls, SD-WAN, Zero Trust Network Access), Prisma Cloud (cloud security posture management, cloud workload protection, CSPM/CWPP), and Cortex (AI-driven security operations — XSIAM extended security intelligence and automation management, XDR endpoint detection and response, XSOAR security orchestration) through approximately 15,000 employees worldwide. In fiscal year 2024 (ending July 2024), Palo Alto Networks reported revenues of $8.0 billion (+16% year-over-year), with next-generation security Annual Recurring Revenue (ARR — Prisma Cloud and Cortex subscriptions) growing 42% to $4.2 billion as large enterprise and government customers consolidated security toolsets onto Palo Alto Networks' platform versus maintaining dozens of point solution security vendors. CEO Nikesh Arora (joined 2018 from SoftBank as Chairman and CEO) has executed the "platformization" strategy — convincing large enterprise security buyers to replace 10-15 individual security vendors (email security, endpoint protection, cloud workload protection, network detection) with a consolidated Palo Alto Networks platform contract that provides 80% of point-solution capabilities at 50% of the total cost — using the first-year transition economics to accelerate platform adoption through deferred commitment offers (paying a lower platform price in year 1 in exchange for multi-year platform commitment in years 2-4).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.